Company Filing History:
Years Active: 2009
Title: Clémence Rey: Innovator in Antibody Research
Introduction
Clémence Rey is a notable inventor based in Munich, Germany. He has made significant contributions to the field of biomedical research, particularly in the development of innovative therapeutic tools.
Latest Patents
Clémence Rey holds a patent for a "Single-chain antibody acting against 37 kDa/67 kDa laminin receptor as tools for the diagnosis and therapy of prion diseases and cancer, production and use thereof." This patent describes single-chain antibodies that specifically recognize both the 37 kDa precursor form and the 67 kDa high-affinity form of the laminin receptor. These antibodies are crucial for developing pharmaceutical and diagnostic compositions aimed at treating prion diseases and cancer.
Career Highlights
Clémence Rey is currently associated with Affimed Therapeutics, a company focused on developing innovative immunotherapies. His work has been instrumental in advancing the understanding and treatment of complex diseases.
Collaborations
He has collaborated with notable colleagues such as Stefan Knackmuss and Peter Röttgen, contributing to a dynamic research environment that fosters innovation.
Conclusion
Clémence Rey's work exemplifies the impact of innovative research in the medical field. His contributions to antibody development are paving the way for new diagnostic and therapeutic options.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.